FDA Approved: MYCOPHENOLIC ACID — Original Application (Novugen Pharma (USA) LLC.)

View source ↗

Summary

FDA approved an original application for mycophenolic acid, enabling a generic version of the immunosuppressant used to prevent organ transplant rejection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant
• Kidney Transplant
• Liver Transplant
• Organ Transplant Rejection Prophylaxis

Drugs mentioned

• Mycophenolic acid (mycophenolic acid)

Snippet

ORIG AP for MYCOPHENOLIC ACID (MYCOPHENOLIC ACID)